Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
5.11
+0.05 (0.99%)
At close: Mar 9, 2026, 4:00 PM EDT
5.18
+0.07 (1.36%)
After-hours: Mar 9, 2026, 4:15 PM EDT
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of $409.66 million as of March 9, 2026. Its market cap has decreased by -5.82% in one year.
Market Cap
409.66M
Enterprise Value
352.66M
1-Year Change
-5.82%
Ranking
Category
Stock Price
$5.11
Market Cap Chart
Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $409.66M, a decrease of -54.97%. That is a compound annual growth rate of -4.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 405.20M | -20.17% |
| Dec 31, 2025 | 507.60M | 25.27% |
| Dec 31, 2024 | 405.20M | 277.28% |
| Dec 29, 2023 | 107.40M | -14.15% |
| Dec 30, 2022 | 125.10M | -51.02% |
| Dec 31, 2021 | 255.40M | -13.89% |
| Dec 31, 2020 | 296.60M | 15.50% |
| Dec 31, 2019 | 256.80M | 35.87% |
| Dec 31, 2018 | 189.00M | -33.29% |
| Dec 29, 2017 | 283.30M | 125.74% |
| Dec 30, 2016 | 125.50M | -5.71% |
| Dec 31, 2015 | 133.10M | 41.45% |
| Dec 31, 2014 | 94.10M | -40.97% |
| Dec 31, 2013 | 159.40M | 224.64% |
| Dec 31, 2012 | 49.10M | 19.76% |
| Dec 30, 2011 | 41.00M | -49.88% |
| Dec 31, 2010 | 81.80M | 544.09% |
| Dec 31, 2009 | 12.70M | -95.35% |
| Dec 31, 2008 | 272.90M | -70.00% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 414.45M |
| Upstream Bio | 413.94M |
| DiaMedica Therapeutics | 413.09M |
| Immutep | 408.45M |
| NovaBridge Biosciences | 403.52M |
| Autolus Therapeutics | 401.88M |
| Crescent Biopharma | 400.89M |
| PureTech Health | 400.20M |